174 related articles for article (PubMed ID: 17121494)
21. IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors.
Cimaz R; Cazalis MA; Reynaud C; Gerloni V; Zulian F; Biggioggero M; Martini G; Pontikaki I; Fantini F; Mougin B; Miossec P
Ann Rheum Dis; 2007 Jul; 66(7):900-4. PubMed ID: 17324969
[TBL] [Abstract][Full Text] [Related]
22. [Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood].
Heiligenhaus A; Horneff G; Greiner K; Mackensen F; Zierhut M; Foeldvari I; Michels H
Klin Monbl Augenheilkd; 2007 Jun; 224(6):526-31. PubMed ID: 17594625
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of etanercept in the treatment of juvenile idiopathic arthritis].
de Inocencio Arocena J; Merino Muñoz R; Alvarez Madrid C; García-Consuegra Molina J
An Pediatr (Barc); 2009 Apr; 70(4):354-61. PubMed ID: 19324597
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs.
Ungar WJ; Costa V; Hancock-Howard R; Feldman BM; Laxer RM
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):111-9. PubMed ID: 20740607
[TBL] [Abstract][Full Text] [Related]
25. Biologic therapies in juvenile idiopathic arthritis: why and for whom?
McCann LJ; Woo P
Acta Reumatol Port; 2007; 32(1):15-26. PubMed ID: 17450761
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
[TBL] [Abstract][Full Text] [Related]
28. The significance of persistent newly developed autoantibodies in JIA patients under long-term anti-TNF treatment.
Kanakoudi-Tsakalidou F; Tzimouli V; Pratsidou-Gertsi P; Chronopoulou E; Trachana M
Cytokine; 2008 Jun; 42(3):293-7. PubMed ID: 18445529
[TBL] [Abstract][Full Text] [Related]
29. New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals.
Beresford MW; Baildam EM
Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):151-6. PubMed ID: 19770495
[TBL] [Abstract][Full Text] [Related]
30. Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents.
Saurenmann RK; Levin AV; Feldman BM; Laxer RM; Schneider R; Silverman ED
J Pediatr; 2006 Dec; 149(6):833-6. PubMed ID: 17137902
[TBL] [Abstract][Full Text] [Related]
31. [New treatments for idiopathic juvenile arthritis].
Bader-Meunier B; Quartier P
Arch Pediatr; 2009 Dec; 16(12):1607-11. PubMed ID: 19896351
[TBL] [Abstract][Full Text] [Related]
32. [Medical treatment of juvenile idiopathic arthritis].
Horneff G; Augustin S
Med Monatsschr Pharm; 2008 Sep; 31(9):326-36; quiz 337-8. PubMed ID: 18831464
[TBL] [Abstract][Full Text] [Related]
33. Juvenile idiopathic arthritis: an update.
Olson JC
WMJ; 2003; 102(7):45-50. PubMed ID: 14711024
[TBL] [Abstract][Full Text] [Related]
34. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
Zulian F; Balzarin M; Falcini F; Martini G; Alessio M; Cimaz R; Cimino L; Zannin ME
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
[TBL] [Abstract][Full Text] [Related]
35. Juvenile idiopathic arthritis: a chronic pediatric musculoskeletal condition with significant orofacial manifestations.
Barr T; Carmichael NM; Sándor GK
J Can Dent Assoc; 2008 Nov; 74(9):813-21. PubMed ID: 19000466
[TBL] [Abstract][Full Text] [Related]
36. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM
Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
[TBL] [Abstract][Full Text] [Related]
37. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?
Butbul YA; Tyrrell PN; Schneider R; Dhillon S; Feldman BM; Laxer RM; Saurenmann RK; Spiegel L; Cameron B; Tse SM; Silverman ED
J Rheumatol; 2009 Sep; 36(9):2033-41. PubMed ID: 19648305
[TBL] [Abstract][Full Text] [Related]
38. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab).
Heiligenhaus A; Miserocchi E; Heinz C; Gerloni V; Kotaniemi K
Rheumatology (Oxford); 2011 Aug; 50(8):1390-4. PubMed ID: 21378109
[TBL] [Abstract][Full Text] [Related]
39. Adult outcomes of patients with juvenile idiopathic arthritis.
Minden K
Horm Res; 2009 Nov; 72 Suppl 1():20-5. PubMed ID: 19940491
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis.
Wulffraat NM; Brinkman D; Ferster A; Opperman J; ten Cate R; Wedderburn L; Foster H; Abinun M; Prieur AM; Horneff G; Zintl F; de Kleer I; Kuis W
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S61-4. PubMed ID: 12931245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
